European Project on Imaging in Stem Cell Therapy

The European Institute for Biomedical Imaging Research (EIBIR), located in Vienna, Austria, has taken over the coordination of a European large-scale research project. An international research group from 10 countries will develop imaging technologies and methods in the area of cell therapy. The project, entitled ENCITE (European Network for Cell Imaging and Tracking Expertise), started June 1, 2008.

Currently, there is no single imaging modality that meets the requirements of stem cell therapy. However, magnetic resonance imaging (MRI) has enormous potential in this regard. Additionally, other imaging methods, especially optical imaging, will be considered in the course of the project.

Within the framework of the project, new MRI imaging methods and biomarkers will be developed and tested in order to get a more comprehensive picture of the cell fate and the reaction of the immune system. Eventually, these are planned to be applied in the treatment of cancer, cardio-vascular diseases and diabetes.

The project is supported by a financial contribution of € 11 m within the European Commission's 7th Framework Programme. EIBIR was founded in January 2006 and is a non-profit, limited liability company with more than 200 member institutions from 27 countries

As the project develops, further highly qualified partners will be needed to contribute either research or dissemination and training activities for the newly developed methods. In order to find these partners, a Competitive Call will be launched in the project ENCITE in autumn 2008.

For further information, please visit:
http://www.eibir.org/

About The European Institute for Biomedical Imaging Research (EIBIR)
The European Institute for Biomedical Imaging Research (EIBIR) promotes networking activities within Europe and ensures the pooling of resources among members to promote a culture of cooperation between them. This will generate critical mass and help coordinate research into new instrumentation, new methods, concepts and technologies.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...